Form 8-K - Current report:
SEC Accession No. 0001104659-25-013029
Filing Date
2025-02-13
Accepted
2025-02-13 17:15:49
Documents
13
Period of Report
2025-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm256594d1_8k.htm   iXBRL 8-K 39895
  Complete submission text file 0001104659-25-013029.txt   215049

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbio-20250207.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20250207_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20250207_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT tm256594d1_8k_htm.xml XML 3565
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 25621624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)